Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-15-043026

Director acquired 547,353 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

SCHIMMEL PAUL · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2015-05-12 Conversion : show line 1 in the form +31,181 31,181 I
2015-05-12 Conversion : show line 2 in the form +470,020 600,015 I
2015-05-12 Conversion : show line 3 in the form +46,152 646,167 I

Table II: Derivative

7 lines
Date Transaction Shares Owned after D/I
2015-05-12 Conversion : show line 4 in the form Series D Redeemable Convertible Preferred Stock −248,024 0 I
2015-05-12 Conversion : show line 5 in the form Series A Redeemable Convertible Preferred Stock −525,000 0 I
2015-05-12 Conversion : show line 6 in the form Series B Redeemable Convertible Preferred Stock −1,200,000 0 I
2015-05-12 Conversion : show line 7 in the form Series B-2 Redeemable Convertible Preferred Stock −1,440,058 0 I
2015-05-12 Conversion : show line 8 in the form Series C Redeemable Convertible Preferred Stock −558,508 0 I
2015-05-12 Conversion : show line 9 in the form Series D Redeemable Convertible Preferred Stock −15,031 0 I
2015-05-12 Conversion : show line 10 in the form Series E Redeemable Convertible Preferred Stock −446,827 0 I
Loading xslF345X03/doc4.xml…